STOCK TITAN

[Form 4] Medtronic plc Insider Trading Activity

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Lincoln Electric Holdings, Inc. (LECO) – Form 144 filing

An insider has filed a Form 144 to sell up to 1,113 common shares through Morgan Stanley Smith Barney on or after 04 Aug 2025. Based on the disclosed aggregate market value of $271,572, the proposal represents roughly 0.002% of the 55.2 million shares outstanding. The shares were originally acquired on 21 Feb 2019 via the company’s Employee Stock Purchase Plan. No other insider sales were reported during the past three months.

The notice contains no new operational or financial information and explicitly states the filer is unaware of undisclosed material adverse data. Given the very small stake involved, the transaction is considered routine portfolio management with minimal expected market impact.

Lincoln Electric Holdings, Inc. (LECO) – Comunicazione Modulo 144

Un insider ha presentato un Modulo 144 per vendere fino a 1.113 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 04 agosto 2025. In base al valore di mercato aggregato dichiarato di 271.572 $, l'operazione rappresenta circa lo 0,002% delle 55,2 milioni di azioni in circolazione. Le azioni sono state acquistate originariamente il 21 febbraio 2019 tramite il Piano di Acquisto Azionario per i Dipendenti della società. Negli ultimi tre mesi non sono state segnalate altre vendite da parte di insider.

La comunicazione non contiene nuove informazioni operative o finanziarie e dichiara esplicitamente che il dichiarante non è a conoscenza di dati materiali negativi non divulgati. Considerando la quota molto ridotta coinvolta, la transazione è considerata una normale gestione del portafoglio con un impatto di mercato minimo previsto.

Lincoln Electric Holdings, Inc. (LECO) – Presentación del Formulario 144

Un insider ha presentado un Formulario 144 para vender hasta 1,113 acciones ordinarias a través de Morgan Stanley Smith Barney a partir del 04 de agosto de 2025. Según el valor de mercado agregado divulgado de $271,572, la propuesta representa aproximadamente el 0.002% de las 55.2 millones de acciones en circulación. Las acciones fueron adquiridas originalmente el 21 de febrero de 2019 mediante el Plan de Compra de Acciones para Empleados de la empresa. No se reportaron otras ventas de insiders en los últimos tres meses.

El aviso no contiene información operativa o financiera nueva y declara explícitamente que el declarante desconoce datos materiales adversos no divulgados. Dado el porcentaje muy pequeño involucrado, la transacción se considera una gestión rutinaria de cartera con un impacto mínimo esperado en el mercado.

Lincoln Electric Holdings, Inc. (LECO) – Form 144 제출

내부자가 2025년 8월 4일 이후 Morgan Stanley Smith Barney를 통해 최대 1,113주 보통주를 판매하기 위해 Form 144를 제출했습니다. 공개된 총 시장 가치 $271,572를 기준으로, 이번 제안은 발행 주식 5,520만 주의 약 0.002%에 해당합니다. 해당 주식은 2019년 2월 21일 회사의 직원 주식 구매 계획을 통해 원래 취득되었습니다. 지난 3개월 동안 다른 내부자 매도는 보고되지 않았습니다.

통지서에는 새로운 운영 또는 재무 정보가 포함되어 있지 않으며, 제출자는 공개되지 않은 중요한 부정적 정보가 없음을 명시적으로 밝히고 있습니다. 매우 적은 지분이 관련되어 있어 이번 거래는 시장에 미치는 영향이 최소화된 일상적인 포트폴리오 관리로 간주됩니다.

Lincoln Electric Holdings, Inc. (LECO) – Dépôt du formulaire 144

Un initié a déposé un formulaire 144 pour vendre jusqu'à 1 113 actions ordinaires via Morgan Stanley Smith Barney à partir du 4 août 2025. Sur la base de la valeur marchande agrégée divulguée de 271 572 $, cette proposition représente environ 0,002 % des 55,2 millions d'actions en circulation. Les actions ont été initialement acquises le 21 février 2019 dans le cadre du plan d'achat d'actions des employés de la société. Aucune autre vente d'initiés n'a été signalée au cours des trois derniers mois.

L'avis ne contient aucune nouvelle information opérationnelle ou financière et indique explicitement que le déposant n'a pas connaissance de données défavorables matérielles non divulguées. Étant donné la très faible participation en jeu, la transaction est considérée comme une gestion de portefeuille courante avec un impact minimal attendu sur le marché.

Lincoln Electric Holdings, Inc. (LECO) – Formular 144 Einreichung

Ein Insider hat ein Formular 144 eingereicht, um bis zu 1.113 Stammaktien über Morgan Stanley Smith Barney ab dem 04. August 2025 zu verkaufen. Basierend auf dem angegebenen aggregierten Marktwert von 271.572 $ entspricht der Vorschlag etwa 0,002 % der 55,2 Millionen ausstehenden Aktien. Die Aktien wurden ursprünglich am 21. Februar 2019 über den Aktienkaufplan für Mitarbeiter des Unternehmens erworben. In den letzten drei Monaten wurden keine weiteren Insiderverkäufe gemeldet.

Die Mitteilung enthält keine neuen operativen oder finanziellen Informationen und erklärt ausdrücklich, dass dem Einreicher keine nicht offengelegten wesentlichen negativen Informationen bekannt sind. Aufgrund des sehr kleinen Anteils wird die Transaktion als routinemäßiges Portfoliomanagement mit minimal erwarteter Marktauswirkung betrachtet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Small insider sale (0.002% float) is routine, immaterial, and unlikely to affect LECO valuation.

The proposed disposition totals just $272k versus LECO’s multi-billion-dollar market cap. Such a minor sale neither signals strategic shifts nor alters supply-demand dynamics. Lack of prior 3-month sales and acquisition via ESPP suggests standard diversification, not negative sentiment. I view the filing as neutral for investors.

TL;DR: Filing shows compliance with Rule 144; no governance red flags detected.

The filer followed proper disclosure protocols, listing broker, acquisition history, and attesting to absence of undisclosed MNPI. Absence of a gifting element and limited share count indicate adherence to internal trading policies. From a governance standpoint, this is non-impactful.

Lincoln Electric Holdings, Inc. (LECO) – Comunicazione Modulo 144

Un insider ha presentato un Modulo 144 per vendere fino a 1.113 azioni ordinarie tramite Morgan Stanley Smith Barney a partire dal 04 agosto 2025. In base al valore di mercato aggregato dichiarato di 271.572 $, l'operazione rappresenta circa lo 0,002% delle 55,2 milioni di azioni in circolazione. Le azioni sono state acquistate originariamente il 21 febbraio 2019 tramite il Piano di Acquisto Azionario per i Dipendenti della società. Negli ultimi tre mesi non sono state segnalate altre vendite da parte di insider.

La comunicazione non contiene nuove informazioni operative o finanziarie e dichiara esplicitamente che il dichiarante non è a conoscenza di dati materiali negativi non divulgati. Considerando la quota molto ridotta coinvolta, la transazione è considerata una normale gestione del portafoglio con un impatto di mercato minimo previsto.

Lincoln Electric Holdings, Inc. (LECO) – Presentación del Formulario 144

Un insider ha presentado un Formulario 144 para vender hasta 1,113 acciones ordinarias a través de Morgan Stanley Smith Barney a partir del 04 de agosto de 2025. Según el valor de mercado agregado divulgado de $271,572, la propuesta representa aproximadamente el 0.002% de las 55.2 millones de acciones en circulación. Las acciones fueron adquiridas originalmente el 21 de febrero de 2019 mediante el Plan de Compra de Acciones para Empleados de la empresa. No se reportaron otras ventas de insiders en los últimos tres meses.

El aviso no contiene información operativa o financiera nueva y declara explícitamente que el declarante desconoce datos materiales adversos no divulgados. Dado el porcentaje muy pequeño involucrado, la transacción se considera una gestión rutinaria de cartera con un impacto mínimo esperado en el mercado.

Lincoln Electric Holdings, Inc. (LECO) – Form 144 제출

내부자가 2025년 8월 4일 이후 Morgan Stanley Smith Barney를 통해 최대 1,113주 보통주를 판매하기 위해 Form 144를 제출했습니다. 공개된 총 시장 가치 $271,572를 기준으로, 이번 제안은 발행 주식 5,520만 주의 약 0.002%에 해당합니다. 해당 주식은 2019년 2월 21일 회사의 직원 주식 구매 계획을 통해 원래 취득되었습니다. 지난 3개월 동안 다른 내부자 매도는 보고되지 않았습니다.

통지서에는 새로운 운영 또는 재무 정보가 포함되어 있지 않으며, 제출자는 공개되지 않은 중요한 부정적 정보가 없음을 명시적으로 밝히고 있습니다. 매우 적은 지분이 관련되어 있어 이번 거래는 시장에 미치는 영향이 최소화된 일상적인 포트폴리오 관리로 간주됩니다.

Lincoln Electric Holdings, Inc. (LECO) – Dépôt du formulaire 144

Un initié a déposé un formulaire 144 pour vendre jusqu'à 1 113 actions ordinaires via Morgan Stanley Smith Barney à partir du 4 août 2025. Sur la base de la valeur marchande agrégée divulguée de 271 572 $, cette proposition représente environ 0,002 % des 55,2 millions d'actions en circulation. Les actions ont été initialement acquises le 21 février 2019 dans le cadre du plan d'achat d'actions des employés de la société. Aucune autre vente d'initiés n'a été signalée au cours des trois derniers mois.

L'avis ne contient aucune nouvelle information opérationnelle ou financière et indique explicitement que le déposant n'a pas connaissance de données défavorables matérielles non divulguées. Étant donné la très faible participation en jeu, la transaction est considérée comme une gestion de portefeuille courante avec un impact minimal attendu sur le marché.

Lincoln Electric Holdings, Inc. (LECO) – Formular 144 Einreichung

Ein Insider hat ein Formular 144 eingereicht, um bis zu 1.113 Stammaktien über Morgan Stanley Smith Barney ab dem 04. August 2025 zu verkaufen. Basierend auf dem angegebenen aggregierten Marktwert von 271.572 $ entspricht der Vorschlag etwa 0,002 % der 55,2 Millionen ausstehenden Aktien. Die Aktien wurden ursprünglich am 21. Februar 2019 über den Aktienkaufplan für Mitarbeiter des Unternehmens erworben. In den letzten drei Monaten wurden keine weiteren Insiderverkäufe gemeldet.

Die Mitteilung enthält keine neuen operativen oder finanziellen Informationen und erklärt ausdrücklich, dass dem Einreicher keine nicht offengelegten wesentlichen negativen Informationen bekannt sind. Aufgrund des sehr kleinen Anteils wird die Transaktion als routinemäßiges Portfoliomanagement mit minimal erwarteter Marktauswirkung betrachtet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Marinaro Michael

(Last) (First) (Middle)
710 MEDTRONIC PARKWAY

(Street)
MINNEAPOLIS MN 55432

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Pres MedSurg and Americas
3. Date of Earliest Transaction (Month/Day/Year)
08/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Ordinary Shares 08/01/2025 M 6,535(1) A $0 57,628 D
Ordinary Shares 08/01/2025 F 3,158(2) D $89.34 54,470 D
Ordinary Shares 08/01/2025 F 1,741(3) D $89.34 52,729 D
Ordinary Shares 08/01/2025 M 3,126 A $78 55,855 D
Ordinary Shares 08/01/2025 F 2,864 D $89.34 52,991 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Performance Share Unit (4) 08/01/2025 M 6,535 (5) (5) Performance Share Units 6,535 $0 0 D
Stock Option (Right to Buy) $78 08/01/2025 M 3,126 (6) 08/03/2025 Ordinary Shares 3,126 $0 0 D
Explanation of Responses:
1. Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents.
2. Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025.
3. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
5. The performance share units vested on August 1, 2025.
6. These options became exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.
Remarks:
/s/ Patricia Walesiewicz, attorney-in-fact 08/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many LECO shares are being proposed for sale under this Form 144?

1,113 common shares are listed for potential sale.

What is the estimated market value of the LECO shares to be sold?

The filing cites an aggregate market value of $271,572.

When can the insider begin selling the LECO shares?

The approximate sale date stated is 08/04/2025.

What percentage of Lincoln Electric’s outstanding shares does this sale represent?

About 0.002% of the 55,186,252 shares outstanding.

How were the shares originally acquired by the insider?

They were purchased through the Employee Stock Purchase Plan on 02/21/2019.
Medtronic

NYSE:MDT

MDT Rankings

MDT Latest News

MDT Latest SEC Filings

MDT Stock Data

114.47B
1.28B
0.27%
86.89%
1.02%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
Ireland
GALWAY